NYU-Regeneron Veterinary Postdoctoral Training Program in Laboratory Animal Medicine
NYU Langone Health, NYU, and Regeneron Pharmaceuticals Inc. are proud to offer an American College of Laboratory Animal Medicine (ACLAM)–recognized three-year postdoctoral training program in laboratory animal medicine. Our training program is led by eight ACLAM-boarded veterinarians and two American College of Veterinary Pathologists (ACVP)–boarded veterinary pathologists.
The three participating institutions contribute to a dynamic curriculum that provides postdocs with the opportunity to work with a wide variety of species; gain an appreciation of the organizational, managerial, and operational differences between three distinctly different research institutions; and gain a broad understanding of the differences between academia and industry. Our combined tri-institutional experience comprehensively prepares the next generation of laboratory animal veterinarians for the many career paths available in the field.
Graduates of American Veterinary Medical Association (AVMA)–accredited schools of veterinary medicine, with a strong interest in laboratory animal medicine, are encouraged to apply through the Veterinary Internship and Residency Matching Program (VIRMP).
Laboratory Animal Medicine Externship
Externship experiences are available for interested veterinary students in their first through fourth years. To apply for an externship experience, please submit a copy of your CV, a letter of interest, and three professional references to Skye Rasmussen, DVM, DACLAM, program co-director, at firstname.lastname@example.org. Our externship experiences require a minimum time commitment of two weeks, and applications must be submitted two months in advance to allow for adequate processing time. Externship opportunities are available for qualified applicants on a first-come, first-served basis.
NYU Langone, an academic medical center, and NYU, a private university, lead research, teaching, and testing programs that include neuroscience and behavior, microbiology, immunology, cancer, cardiology, surgery, diagnostic imaging, and endocrinology. NYU Grossman School of Medicine, part of NYU Langone, is ranked No. 2 in the nation for research on U.S. News & World Report’s 2022 “Best Graduate Schools” rankings. It is important to highlight that the two participating NYU institutions are distinct and separate from one another, and, as a result, have very different work cultures, operational practices, and organizational structures.
Regeneron is a leading science-based, fully integrated biopharmaceutical company that discovers, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases and colorectal cancer, among other conditions, and has product candidates in development in areas of high unmet medical need such as hypercholesterolemia, rheumatoid arthritis, and asthma. Most recently, Regeneron successfully developed an antibody cocktail against Ebola and against coronavirus disease (COVID-19).
For general inquiries about our training program, please email Dr. Rasmussen at email@example.com.